GLYcoDiag is proud to announce its participation as beneficiary to HORIZON-TMA-MSCA-DN program called AUREUS
The AUREUS doctoral network (DN) meets the increasing need of a highly qualified work force to counteract multidrug-resistant S.aureus infections by performing cutting-edge, inter-disciplinary research